#GivingTuesday is November 29th 2022! Help give a voice to a widely unknown disease. Donate this #GivingTuesday to the PKD Foundation of Canada, the only national organization solely dedicated to fighting PKD through research, education, advocacy, support and awareness.
With 2019 drawing to a close, we hope you remember the PKD Foundation of Canada in your holiday plans and consider making a year-end gift to help advance Canadian research, advocacy and support for more PKD patients and their loved ones.
Michael Coyle was a new Search-and-Rescue (SAR) recruit in British Columbia two decades ago when his blood pressure showed up abnormally high during training. As it turned out, it was the beginning of the road to a diagnosis that would change his life.
(Toronto, Canada – October 3, 2019) Dr. York Pei, an award-winning scientist at the University Health Network, has discovered a potential new use for an old drug, providing hope for patients suffering from polycystic kidney disease.
In a pre-clinical trial, Dr. Pei found Salsalate, a drug in the aspirin family, and an approved drug therapy for rheumatism, was successfully used to improve kidney survival and reduced cystic kidney disease severity.
PKD affects thousands in Canada and millions worldwide, yet many people have never heard of it. Together, we can change this! #PKDAwarenessDay (#Sept4) is our day to raise awareness about this disease and the negative impact it has on generation after generation. Don't forget to use #PKDAwarenessDay and #endPKD to join the online conversation. The more people that know about #PKD, the closer we can get to treatments and a cure. Together, let's raise awareness and end PKD!
Join us for the 2019 Walk to END PKD, the PKD Foundation of Canada's signature fundraising campaign!
Bike to the Moon is a PKD Foundation of Canada annual fundraiser for both casual and serious cyclists, taking place June 21-24, 2019 in your own community and on your own route! Collectively, we aim to bike the distance to the moon (384,400 km) and raise critical funds for the Hereditary Kidney Disease Program at Toronto General Hospital.